首页> 外国专利> PREDICTION PROCEDURE OF SIMVASTATIN BASED CLINICAL EFFECTIVENESS WITH REGARD TO RHEUMATOID ARTHRITIS

PREDICTION PROCEDURE OF SIMVASTATIN BASED CLINICAL EFFECTIVENESS WITH REGARD TO RHEUMATOID ARTHRITIS

机译:关于类风湿关节炎的基于辛伐他汀的临床疗效的预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to the prediction procedures of simvastatin based clinical effectiveness with regard to rheumatoid arthritis, and concerns applications of simvastatin in rheumatoid arthritis therapy. It is based on estimation cytokine profile in the patients suffering from rheumatoid arthritis. Prior to the therapy, the patients with rheumatoid arthritis are examined for amount of serum interleukin-10 which if makes 6.5 pg/ml allows predicting effective clinical response to simvastatin based therapy.;EFFECT: method provides individualisation of administered simvastatin based therapy.;1 tbl, 5 dwg
机译:技术领域本发明涉及医学,即基于类风湿性关节炎的基于辛伐他汀的临床疗效的预测程序,并且涉及辛伐他汀在类风湿性关节炎治疗中的应用。它基于对类风湿关节炎患者的细胞因子分布的估计。在治疗之前,对类风湿关节炎患者的血清白细胞介素10的量进行检查,如果血清白细胞介素10的浓度为6.5 pg / ml,则可以预测对基于辛伐他汀的疗法的有效临床反应。 tbl,5 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号